title: Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
abstract: Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high relapse rate of the disease, there is a pressing need for development of alternate protection strategies. Antibody-mediated passive protection is promising in this regard and our primary interest was to unravel this frontier of specific mAbs against Burkholderia pseudomallei infections, as functional characterization of antibodies is a pre-requisite to demonstrate them as protective molecules. To achieve this, we designed our study on in vitro-based approach and assessed two mAbs, namely BURK24 and BURK37, reactive with outer membrane proteins and lipopolysaccharide of the pathogen respectively, for their ability to manifest inhibitory effects on the pathogenesis mechanisms of B. pseudomallei including biofilm formation, invasion and induction of apoptosis. The experiments were performed using B. pseudomallei standard strain NCTC 10274 and a clinical isolate, B. pseudomallei 621 recovered from a septicemia patient with diabetic ailment. The growth kinetic studies of the pathogen in presence of various concentrations of each individual mAb revealed their anti-bacterial properties. Minimal inhibitory concentration and minimal bactericidal concentration of both the mAbs were determined by using standards of Clinical and Laboratory Standards Institute (CLSI) and experiments were performed using individual mAbs at their respective bacteriostatic concentration. As an outcome, both mAbs exhibited significant anti-Burkholderia pseudomallei properties. They limited the formation of biofilm by the bacterium and completely crippled its invasion into human alveolar adenocarcinoma epithelial cells. Also, the mAbs were appreciably successful in preventing the bacterium to induce apoptosis in A549 cells. The present study design revealed the protection attributes possessed by BURK24 and BURK37 that has to be further substantiated by additional in vivo studies.
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Bhavani V
authors.initials: BV
authors.lastname: Peddayelachagiri
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Soumya
authors.initials: S
authors.lastname: Paul
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Shivakiran S
authors.initials: SS
authors.lastname: Makam
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Radhika M
authors.initials: RM
authors.lastname: Urs
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Joseph J
authors.initials: JJ
authors.lastname: Kingston
authors.affiliation: Microbiology Division, Defence Research and Development Establishment, Gwalior, Madhya Pradesh, India.
authors.forename: Urmil
authors.initials: U
authors.lastname: Tuteja
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Murali H
authors.initials: MH
authors.lastname: Sripathy
authors.affiliation: Microbiology Division, Defence Food Research Laboratory, Mysore, Karnataka, India.
authors.forename: Harsh V
authors.initials: HV
authors.lastname: Batra
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000890:Anti-Infective Agents / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D000918:Antibody Specificity / Q000276:immunology; D017209:Apoptosis / Q000187:drug effects; D018441:Biofilms / Q000187:drug effects; D016957:Burkholderia pseudomallei / Q000187:drug effects* / Q000276:immunology; D002460:Cell Line; D048430:Cell Shape / Q000187:drug effects; D004249:DNA Damage; D000939:Epitopes / Q000276:immunology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007114:Immunization; D007700:Kinetics; D008807:Mice, Inbred BALB C; D008826:Microbial Sensitivity Tests; D020011:Protective Agents / Q000494:pharmacology*; D011485:Protein Binding; D013997:Time Factors
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000911:Antibodies, Monoclonal; D000939:Epitopes; D020011:Protective Agents